Evogene Ltd. announced today that it will present a company overview at the Aegis Capital Corp. Virtual Conference to be held on February 25th at 9:00 Eastern.
REHOVOT, Israel, Feb. 7, 2022 /PRNewswire/ -- Evogene Ltd. (NASDAQ-GM: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments announced today that it will present a company overview at the Aegis Capital Corp. Virtual Conference to be held on February 25th at 9:00 Eastern. The conference will span three days, starting on February 23rd until February 25th from 8:30AM until 5PM EST. ![]() Evogene's presentation will be available by request to Aegis from February 23 to 25, 2022. The slide deck will also be made available on Evogene's website at https://www.evogene.com/investor-relations/presentations-and-webcasts/. To access the event, please download and import the following iCalendar (.ics) files to your calendar system: Aegis Virtual Conference Calendar About Evogene Ltd.: Evogene (NASDAQ-GM: EVGN) (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ag Ltd. For more information, please visit www.evogene.com. Contact: Rivka Neufeld US Investor Relations: Joseph Green Laine Yonker Logo: https://mma.prnewswire.com/media/890385/Evogene_Logo.jpg
SOURCE Evogene Ltd |
||
Company Codes: NASDAQ-NMS:EVGN, ISIN:IL0011050551, TelAviv:EVGN, OtherOTC:EVGN |